Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 63 | 2024 | 13102 | 5.970 |
Why?
|
Cryosurgery | 12 | 2023 | 453 | 5.070 |
Why?
|
Sarcopenia | 12 | 2023 | 368 | 4.420 |
Why?
|
Tomography, X-Ray Computed | 58 | 2023 | 20129 | 2.800 |
Why?
|
Early Detection of Cancer | 19 | 2024 | 3086 | 2.340 |
Why?
|
Pneumonectomy | 6 | 2021 | 1094 | 2.300 |
Why?
|
Body Composition | 10 | 2022 | 2401 | 1.920 |
Why?
|
Lung Diseases, Interstitial | 5 | 2023 | 808 | 1.740 |
Why?
|
Catheter Ablation | 6 | 2023 | 2758 | 1.740 |
Why?
|
Thoracic Wall | 3 | 2019 | 203 | 1.740 |
Why?
|
Muscle, Skeletal | 12 | 2023 | 4931 | 1.700 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2024 | 5221 | 1.540 |
Why?
|
Ablation Techniques | 4 | 2021 | 249 | 1.510 |
Why?
|
Radiography, Interventional | 4 | 2021 | 1095 | 1.040 |
Why?
|
Radiosurgery | 3 | 2024 | 1329 | 0.990 |
Why?
|
Lung | 23 | 2023 | 9856 | 0.930 |
Why?
|
Radiography, Thoracic | 6 | 2020 | 1265 | 0.930 |
Why?
|
Radiographic Image Enhancement | 2 | 2021 | 885 | 0.840 |
Why?
|
Retrospective Studies | 43 | 2024 | 77449 | 0.810 |
Why?
|
Microwaves | 5 | 2023 | 191 | 0.780 |
Why?
|
Hemoptysis | 2 | 2021 | 155 | 0.750 |
Why?
|
Biopsy, Needle | 8 | 2023 | 1641 | 0.740 |
Why?
|
Mass Screening | 7 | 2023 | 5255 | 0.710 |
Why?
|
Pneumonia | 6 | 2023 | 2133 | 0.690 |
Why?
|
Adipose Tissue | 3 | 2021 | 3279 | 0.660 |
Why?
|
Aged | 56 | 2024 | 163280 | 0.650 |
Why?
|
Hyperthermia, Induced | 1 | 2022 | 403 | 0.650 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2021 | 252 | 0.650 |
Why?
|
Humans | 123 | 2024 | 744343 | 0.600 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2019 | 266 | 0.600 |
Why?
|
Embolism, Air | 1 | 2017 | 111 | 0.600 |
Why?
|
Pleural Neoplasms | 2 | 2019 | 607 | 0.590 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2019 | 740 | 0.580 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 451 | 0.580 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 428 | 0.560 |
Why?
|
Radiology Information Systems | 2 | 2017 | 523 | 0.540 |
Why?
|
Middle Aged | 52 | 2023 | 213383 | 0.520 |
Why?
|
Catecholamines | 1 | 2015 | 387 | 0.500 |
Why?
|
Male | 65 | 2024 | 350118 | 0.490 |
Why?
|
Female | 62 | 2024 | 380194 | 0.480 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1094 | 0.470 |
Why?
|
Radiology | 5 | 2023 | 2100 | 0.470 |
Why?
|
Adrenalectomy | 1 | 2015 | 341 | 0.460 |
Why?
|
Practice Management, Medical | 1 | 2015 | 196 | 0.450 |
Why?
|
Brachytherapy | 1 | 2021 | 1248 | 0.440 |
Why?
|
Immunotherapy | 4 | 2020 | 4445 | 0.440 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2291 | 0.430 |
Why?
|
Contrast Media | 5 | 2023 | 5300 | 0.430 |
Why?
|
Lung Diseases | 2 | 2020 | 1886 | 0.430 |
Why?
|
Body Mass Index | 7 | 2022 | 12720 | 0.400 |
Why?
|
Aged, 80 and over | 25 | 2022 | 57776 | 0.380 |
Why?
|
Treatment Outcome | 15 | 2024 | 63114 | 0.380 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1392 | 0.380 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3047 | 0.370 |
Why?
|
Weight Loss | 2 | 2021 | 2622 | 0.370 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9274 | 0.370 |
Why?
|
Sarcoma | 1 | 2021 | 1897 | 0.360 |
Why?
|
Postoperative Complications | 4 | 2020 | 15295 | 0.360 |
Why?
|
Thorax | 2 | 2023 | 547 | 0.350 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 990 | 0.340 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 1364 | 0.340 |
Why?
|
Preoperative Care | 1 | 2017 | 2250 | 0.310 |
Why?
|
Jejunal Diseases | 1 | 2008 | 50 | 0.310 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4262 | 0.310 |
Why?
|
Critical Illness | 2 | 2017 | 2670 | 0.310 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.300 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2214 | 0.300 |
Why?
|
Neoplasms | 7 | 2023 | 21683 | 0.300 |
Why?
|
Palliative Care | 2 | 2019 | 3493 | 0.300 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.300 |
Why?
|
Length of Stay | 5 | 2022 | 6309 | 0.290 |
Why?
|
Diverticulum | 1 | 2008 | 136 | 0.290 |
Why?
|
Radiation Dosage | 4 | 2022 | 1928 | 0.280 |
Why?
|
Fluoroscopy | 3 | 2022 | 924 | 0.260 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4253 | 0.260 |
Why?
|
Pain | 1 | 2019 | 4986 | 0.240 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 518 | 0.240 |
Why?
|
Forced Expiratory Volume | 2 | 2019 | 1743 | 0.240 |
Why?
|
Glycolates | 1 | 2023 | 40 | 0.240 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.230 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2011 | 1052 | 0.220 |
Why?
|
Incidental Findings | 2 | 2019 | 689 | 0.220 |
Why?
|
Tomography | 2 | 2021 | 390 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6234 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 35421 | 0.200 |
Why?
|
Hemothorax | 1 | 2021 | 60 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.200 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 13695 | 0.190 |
Why?
|
Adult | 21 | 2023 | 214055 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9239 | 0.180 |
Why?
|
Point-of-Care Systems | 2 | 2020 | 1177 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5442 | 0.180 |
Why?
|
Survival Analysis | 3 | 2021 | 10252 | 0.180 |
Why?
|
Acrylamides | 2 | 2018 | 255 | 0.180 |
Why?
|
Rotation | 1 | 2021 | 523 | 0.180 |
Why?
|
High-Frequency Jet Ventilation | 1 | 2019 | 23 | 0.180 |
Why?
|
Intensive Care Units | 3 | 2017 | 3679 | 0.180 |
Why?
|
Hospitals | 3 | 2024 | 3952 | 0.180 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39050 | 0.170 |
Why?
|
Enterocolitis | 1 | 2020 | 102 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15165 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6538 | 0.170 |
Why?
|
Subclavian Artery | 2 | 2017 | 130 | 0.170 |
Why?
|
Preoperative Period | 1 | 2021 | 549 | 0.170 |
Why?
|
Cohort Studies | 6 | 2024 | 40561 | 0.170 |
Why?
|
Prognosis | 8 | 2023 | 29063 | 0.170 |
Why?
|
Reference Values | 2 | 2023 | 4982 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 530 | 0.160 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15076 | 0.160 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 373 | 0.160 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 1184 | 0.160 |
Why?
|
Aspergillosis | 1 | 2020 | 235 | 0.160 |
Why?
|
Melanoma | 3 | 2022 | 5510 | 0.150 |
Why?
|
Depression | 1 | 2017 | 7766 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2023 | 881 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2018 | 71 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2024 | 3507 | 0.150 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2278 | 0.150 |
Why?
|
Pneumothorax | 1 | 2021 | 379 | 0.150 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 537 | 0.150 |
Why?
|
United States | 12 | 2022 | 69872 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2019 | 153 | 0.150 |
Why?
|
Aniline Compounds | 2 | 2018 | 986 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.140 |
Why?
|
Wireless Technology | 1 | 2017 | 100 | 0.140 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 273 | 0.140 |
Why?
|
Electric Impedance | 1 | 2020 | 729 | 0.140 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 413 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1180 | 0.140 |
Why?
|
Quality of Life | 1 | 2017 | 12804 | 0.140 |
Why?
|
Internet | 3 | 2022 | 3064 | 0.140 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2015 | 30 | 0.140 |
Why?
|
Takayasu Arteritis | 1 | 2017 | 96 | 0.130 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1257 | 0.130 |
Why?
|
Internship and Residency | 3 | 2024 | 5788 | 0.130 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2017 | 288 | 0.130 |
Why?
|
Fibrosis | 1 | 2022 | 2029 | 0.130 |
Why?
|
Quadriceps Muscle | 1 | 2016 | 144 | 0.130 |
Why?
|
Risk Factors | 8 | 2021 | 72290 | 0.130 |
Why?
|
Photons | 1 | 2019 | 588 | 0.130 |
Why?
|
Disease Progression | 4 | 2019 | 13284 | 0.130 |
Why?
|
Positive-Pressure Respiration | 1 | 2019 | 633 | 0.130 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 391 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2022 | 8642 | 0.120 |
Why?
|
Medical Record Linkage | 1 | 2016 | 284 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 611 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3327 | 0.120 |
Why?
|
Pleura | 1 | 2015 | 235 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1372 | 0.120 |
Why?
|
Celiac Disease | 1 | 2022 | 785 | 0.120 |
Why?
|
Survival Rate | 5 | 2019 | 12788 | 0.120 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.120 |
Why?
|
Thymoma | 1 | 2015 | 186 | 0.120 |
Why?
|
Coronary-Subclavian Steal Syndrome | 1 | 2013 | 2 | 0.120 |
Why?
|
Societies, Medical | 2 | 2015 | 3743 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 525 | 0.110 |
Why?
|
Clinical Competence | 2 | 2024 | 4687 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 795 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1350 | 0.110 |
Why?
|
Colitis | 1 | 2021 | 1170 | 0.110 |
Why?
|
Prescriptions | 1 | 2015 | 387 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12245 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1486 | 0.110 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2274 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2124 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 591 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2018 | 664 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 793 | 0.110 |
Why?
|
Cysts | 1 | 2018 | 678 | 0.110 |
Why?
|
Prospective Studies | 6 | 2023 | 53288 | 0.110 |
Why?
|
Models, Organizational | 1 | 2016 | 574 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.110 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 397 | 0.100 |
Why?
|
Time Factors | 5 | 2021 | 40075 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 581 | 0.100 |
Why?
|
Frail Elderly | 1 | 2016 | 693 | 0.100 |
Why?
|
Colon | 2 | 2020 | 1772 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 547 | 0.100 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25043 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 961 | 0.100 |
Why?
|
Registries | 2 | 2018 | 8089 | 0.100 |
Why?
|
Workflow | 1 | 2016 | 847 | 0.100 |
Why?
|
Risk | 1 | 2023 | 9687 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2043 | 0.100 |
Why?
|
Hospital Costs | 1 | 2017 | 985 | 0.100 |
Why?
|
Thyrotropin | 1 | 2014 | 849 | 0.100 |
Why?
|
Carcinoma | 1 | 2022 | 2375 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3474 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 665 | 0.090 |
Why?
|
Biopsy | 3 | 2017 | 6756 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3339 | 0.090 |
Why?
|
Focus Groups | 1 | 2015 | 1321 | 0.090 |
Why?
|
Retreatment | 1 | 2012 | 610 | 0.090 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12959 | 0.090 |
Why?
|
Smoking | 2 | 2018 | 8987 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 760 | 0.090 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.090 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1353 | 0.090 |
Why?
|
Pain Measurement | 1 | 2019 | 3420 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2016 | 696 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11524 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2014 | 658 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 868 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4776 | 0.090 |
Why?
|
Patient Positioning | 1 | 2012 | 324 | 0.090 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5756 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.080 |
Why?
|
Lipoma | 1 | 2011 | 334 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2016 | 0.080 |
Why?
|
Barium Sulfate | 1 | 2008 | 180 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3143 | 0.080 |
Why?
|
Artifacts | 2 | 2017 | 1904 | 0.080 |
Why?
|
Obesity | 3 | 2019 | 12745 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12354 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 1848 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2645 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10397 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.070 |
Why?
|
Research | 1 | 2015 | 1999 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8663 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2019 | 3528 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4217 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8949 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2951 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4034 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1164 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3158 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.070 |
Why?
|
Dyspnea | 3 | 2020 | 1303 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2957 | 0.060 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2016 | 143 | 0.060 |
Why?
|
Cough | 2 | 2020 | 555 | 0.060 |
Why?
|
Neoplasm Staging | 4 | 2022 | 11031 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5319 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.060 |
Why?
|
Quality Assurance, Health Care | 2 | 2012 | 2212 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6364 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3114 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18370 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2013 | 1786 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2133 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 20947 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 178 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1660 | 0.060 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.060 |
Why?
|
Models, Biological | 1 | 2019 | 9583 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3251 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Health Personnel | 1 | 2015 | 3218 | 0.050 |
Why?
|
Multimedia | 1 | 2022 | 77 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14722 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3887 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
Tomography, Spiral Computed | 1 | 2022 | 280 | 0.050 |
Why?
|
Logistic Models | 1 | 2015 | 13408 | 0.050 |
Why?
|
Search Engine | 1 | 2022 | 144 | 0.050 |
Why?
|
Collagen Type I | 1 | 2023 | 592 | 0.050 |
Why?
|
Quality Improvement | 1 | 2015 | 3749 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2538 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4838 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4468 | 0.040 |
Why?
|
Curriculum | 2 | 2024 | 3605 | 0.040 |
Why?
|
Prone Position | 1 | 2019 | 194 | 0.040 |
Why?
|
Cell Growth Processes | 1 | 2019 | 399 | 0.040 |
Why?
|
Keratin-8 | 1 | 2017 | 11 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1000 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7279 | 0.040 |
Why?
|
Keratin-18 | 1 | 2017 | 39 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19905 | 0.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.040 |
Why?
|
Sweating | 1 | 2017 | 123 | 0.040 |
Why?
|
Thrombocytosis | 1 | 2017 | 81 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.040 |
Why?
|
Molecular Imaging | 1 | 2023 | 828 | 0.040 |
Why?
|
Iopamidol | 1 | 2016 | 191 | 0.030 |
Why?
|
Cisplatin | 1 | 2022 | 1662 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 251 | 0.030 |
Why?
|
Testicular Neoplasms | 1 | 2022 | 804 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 320 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 20822 | 0.030 |
Why?
|
Erythema | 1 | 2017 | 257 | 0.030 |
Why?
|
Radiography | 2 | 2020 | 7023 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2297 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2689 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 686 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 2016 | 310 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1524 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3479 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2902 | 0.030 |
Why?
|
Hoarseness | 1 | 2014 | 65 | 0.030 |
Why?
|
Sacrum | 1 | 2016 | 288 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56430 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 10900 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2016 | 4577 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 542 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.030 |
Why?
|
Rhabdomyolysis | 1 | 2014 | 150 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2017 | 696 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2014 | 418 | 0.030 |
Why?
|
Fibromyalgia | 1 | 2017 | 388 | 0.030 |
Why?
|
Eosinophilia | 1 | 2017 | 541 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 215 | 0.030 |
Why?
|
Creatine Kinase | 1 | 2014 | 694 | 0.030 |
Why?
|
Exons | 1 | 2018 | 2437 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 608 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2014 | 390 | 0.030 |
Why?
|
Polypharmacy | 1 | 2014 | 294 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 944 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2015 | 598 | 0.020 |
Why?
|
Travel | 1 | 2017 | 788 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.020 |
Why?
|
Thyroxine | 1 | 2014 | 667 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1442 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1226 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6314 | 0.020 |
Why?
|
Nursing Homes | 1 | 2016 | 1036 | 0.020 |
Why?
|
Skin Diseases | 1 | 2017 | 1065 | 0.020 |
Why?
|
Diarrhea | 1 | 2015 | 1348 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1807 | 0.020 |
Why?
|
Automation | 1 | 2010 | 584 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6895 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1506 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1531 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1972 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4215 | 0.020 |
Why?
|
Piperazines | 1 | 2017 | 2488 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2825 | 0.020 |
Why?
|
Bone Marrow | 1 | 2015 | 2948 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9313 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4149 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5172 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2010 | 1431 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2063 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5317 | 0.010 |
Why?
|
Spinal Cord | 1 | 2011 | 1809 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6566 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3255 | 0.010 |
Why?
|
Brain | 2 | 2020 | 26385 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8863 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81183 | 0.010 |
Why?
|
Software | 1 | 2010 | 4443 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168757 | 0.010 |
Why?
|